Validated UHPLC-MS/MS method for quantification of doxycycline in abdominal aortic aneurysm patients.
Bioanalysis
; 10(8): 527-539, 2018 Apr 01.
Article
en En
| MEDLINE
| ID: mdl-29633854
ABSTRACT
AIM:
There is a strong evidence that doxycycline can benefit abdominal aortic aneurysms patients because of its ability to inhibit matrix metalloproteinase enzymes. There is a need for a specific quantification method for doxycycline in these patients. We report herein the development and validation of a selective, specific, simple and rapid UHPLC-MS/MS method for doxycycline.RESULTS:
The assay was linear (r2 > 0.994) over a concentration range of 0.010-7.005 µg/ml. This validated method has good lower limit of quantification (LLOQ) (10 ng/ml), accuracies (89.1-103.4%), precision (≤7.0%) and extraction recoveries (95.8%). Doxycycline was stable during short- and long-term storage.CONCLUSION:
The assay is reliable and has been successfully applied to serum samples obtained from the patients of N-TA3CT clinical study.Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Cromatografía Líquida de Alta Presión
/
Aneurisma de la Aorta Abdominal
/
Doxiciclina
/
Espectrometría de Masas en Tándem
/
Antibacterianos
Idioma:
En
Revista:
Bioanalysis
Año:
2018
Tipo del documento:
Article